Latest News from "The Pink Sheet" DAILY

DoJ Claims J&J Paid Kickbacks To Pharmacy To Boost Risperdal Use In Nursing Homes

The complaint says J&J paid Omnicare rebates to intervene in physician prescribing and sought to keep "best prices" down by substituting rebate payments for the purchase of Omnicare data.   read more

 

Venture Data Continues To Haunt The Biotech Landscape

Venture firms suffered fundraising woes last year, and a handful of biopharma funds stopped investing. It could get worse.   read more

 

Financings Of The Fortnight: Paul Capital Healthcare, ZymoGenetics, Regado, BIND

Recent biotech IPO hopefuls have some interesting characteristics in common.   read more

 

Pfizer Research Grant Recipient Charged With Falsifying Study Results

Department of Justice alleges that Massachusetts anesthesiologist Scott Rueben published fake results of studies he never conducted.   read more

 

Drug Utilization Management Continues To Rise On Part D Formularies, MedPAC Says

Nearly one-third of chemical entities on Medicare Part D prescription drug plan formularies face some kind of utilization management in 2010, MedPAC reports.   read more

 

An Interview With PharmAsia News: Pharmatech's Bikash Chatterjee And Chat Kwan On China's New GMP Guidelines

China's shift to a global standard means companies must invest in a more reproducible supply chain, which translates to a more predictable manufacturing and distribution operation.   read more

 

"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here